Rick Yang has bought stock on 5 days since Jul 2023

Rick Yang is a venture capital professional serving as the manager of NEA 17 GP, LLC, which indirectly controls New Enterprise Associates 17, L.P. (NEA 17), a significant investor in SpyGlass Pharma, Inc. (SGP).( As a Section 16 reporting person and beneficial owner through NEA 17, he is listed as a corporate insider at SGP, reflecting his influential role in the firm's investment activities.(

On February 9, 2026, coinciding with SGP's initial public offering, NEA 17 converted its preferred stock (Series B, C-1, C-2, and D) into common shares on a one-for-one basis and purchased an additional 937,500 shares at $16 per share, increasing its holdings to 6,035,038 shares.( Rick Yang disclaims beneficial ownership except to the extent of his pecuniary interest, underscoring his position within the New Enterprise Associates structure.(

Written by Perplexity from public sources.